Sakar Healthcare

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE732S01012
NSEID: SAKAR
BSEID:

INR

375.90

-9.65 (-2.5%)

BSENSE

Dec 05

BSE+NSE Vol: 12038

{
  "main_header": {
    "sid": 1002668,
    "name": "Sakar Healthcare",
    "stock_name": "Sakar Healthcare",
    "full_name": "Sakar Healthcare Ltd",
    "name_url": "stocks-analysis/sakar-healthcare",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "375.90",
    "chg": -9.65,
    "chgp": "-2.5%",
    "dir": -1,
    "prev_price": "385.55",
    "mcapval": "853.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SAKAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE732S01012",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 12038,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sakar-healthcare-1002668-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Sakar Healthcare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sakar-healthcare-fallingrising-3742507",
        "imagepath": "",
        "date": "2025-12-03 00:53:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Consistent Growth Driving Investor Optimism</strong></p>\n<p>Sakar Healthcare’s recent price appreciation is underpinned by its impressive financial results over the past several quarters. The company has reported positive earnings for four consecutive quarters, signalling operational stability and growth momentum. In the latest six-month period, net sales surged to ₹110.30 crores, marking a substantial growth rate of 31.42%. This top-line expansion has translated into a healthy rise in profitability, with the profit after tax (PAT) reaching ₹9.21 crores, up 27.74% compared to the previous period. Such strong earnings growth has bolstered investor sentiment, contributing to the stock’s upward trajectory.</p>\n<p><strong>Market Outperformance and Technical Strength</strong></p>\n<p>Beyond fundam..."
      },
      {
        "title": "Sakar Healthcare Sees Revision in Market Evaluation Amid Positive Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-upgraded-from-sell-to-hold-by-marketsmojo-on-15-sep-2025-3737230",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SakarHealthcare_mojoScore_3737230.png",
        "date": "2025-11-30 10:24:23",
        "description": "Sakar Healthcare, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical indicators, providing investors with a refreshed view of its market position."
      },
      {
        "title": "Sakar Healthcare Technical Momentum Shifts Signal Bullish Trends Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-technical-momentum-shifts-to-bullish-amid-strong-yearly-gains-3734726",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SakarHealthcare_technicaldot_3734726.png",
        "date": "2025-11-28 08:07:24",
        "description": "Sakar Healthcare, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited notable shifts in its technical momentum, reflecting evolving market dynamics. Recent assessment changes highlight a transition towards bullish technical indicators, suggesting a potential strengthening in price trends despite mixed signals from volume-based metrics."
      },
      {
        "title": "Sakar Healthcare Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-technical-momentum-shifts-amid-mixed-market-signals-3732569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SakarHealthcare_technicaldot_3732569.png",
        "date": "2025-11-27 08:07:49",
        "description": "Sakar Healthcare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, underscoring the evolving market dynamics for this mid-cap stock."
      },
      {
        "title": "Sakar Healthcare Technical Momentum Shifts Signal Renewed Market Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-technical-momentum-shifts-to-bullish-amid-strong-returns-3730335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SakarHealthcare_technicaldot_3730335.png",
        "date": "2025-11-26 08:09:08",
        "description": "Sakar Healthcare has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent assessment changes highlight a transition from a mildly bullish to a bullish technical trend, supported by key indicators such as MACD, moving averages, and Bollinger Bands, suggesting a renewed investor focus on the stock."
      },
      {
        "title": "Sakar Healthcare Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-technical-momentum-shifts-amid-mixed-market-signals-3727622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SakarHealthcare_technicaldot_3727622.png",
        "date": "2025-11-25 08:13:20",
        "description": "Sakar Healthcare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the importance of a detailed technical analysis for investors tracking this stock."
      },
      {
        "title": "Sakar Healthcare Shows Resilience Amidst Mixed Financial Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcares-financial-trend-improves-from-flat-to-positive-amid-rising-profit-after-tax-3692447",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SakarHealthcare_fintrenddot_3692447.png",
        "date": "2025-11-12 11:01:22",
        "description": "Sakar Healthcare has reported positive financial results for the quarter ending September 2025, with a notable increase in profit after tax and strong net sales. However, rising interest expenses and declining profitability metrics present challenges. The company has outperformed the Sensex, highlighting its market resilience."
      },
      {
        "title": "How has been the historical performance of Sakar Healthcare?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sakar-healthcare-3683556",
        "imagepath": "",
        "date": "2025-11-09 22:42:04",
        "description": "Answer:\nThe historical performance of Sakar Healthcare shows a consistent growth trajectory in net sales and profitability over the past five years.\n\nBreakdown:\nSakar Healthcare's net sales have increased from 94.74 Cr in Mar'21 to 177.58 Cr in Mar'25, demonstrating a strong upward trend. Total operating income has followed a similar pattern, rising from 94.74 Cr in Mar'21 to 177.58 Cr in Mar'25. The company's total expenditure has also grown, reaching 127.90 Cr in Mar'25, up from 72.14 Cr in Mar'21, primarily driven by rising raw material costs and employee expenses. Operating profit (PBDIT) has improved significantly, from 22.60 Cr in Mar'21 to 49.68 Cr in Mar'25, indicating enhanced operational efficiency. Profit before tax has increased from 13.23 Cr in Mar'21 to 21.53 Cr in Mar'25, while profit after tax has risen from 10.68 Cr in Mar'21 to 17.50 Cr in Mar'25. The company's earnings per share (EPS) hav..."
      },
      {
        "title": "Are Sakar Healthcare latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sakar-healthcare-latest-results-good-or-bad-3682453",
        "imagepath": "",
        "date": "2025-11-08 19:20:12",
        "description": "Sakar Healthcare's latest financial results for Q2 FY26 highlight a complex operational landscape characterized by significant revenue growth juxtaposed with margin compression and rising costs. The company reported a revenue of ₹52.74 crores, marking a 28.17% increase year-on-year and a 4.98% increase quarter-on-quarter, which reflects a strong sales performance. However, net profit was ₹4.67 crores, showing a substantial year-on-year increase of 93.78% but a decline of 18.92% compared to the previous quarter, indicating volatility in profitability.\n\nThe operating margin, excluding other income, decreased to 24.10% from 26.00% year-on-year, signaling challenges in maintaining operational efficiency amidst rising employee costs and operational expenses that have outpaced revenue growth. The profit after tax margin improved to 8.85% year-on-year but fell from 11.46% in the previous quarter, suggesting potent..."
      }
    ],
    "total": 368,
    "sid": "1002668",
    "stock_news_url": "https://www.marketsmojo.com/news/sakar-healthcare-1002668"
  },
  "announcements": [
    {
      "details": "Sakar Healthcare Limitedealthcare Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limitede Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Clarification - Financial Results",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Sakar Healthcare falling/rising?

2025-12-03 00:53:37

Consistent Growth Driving Investor Optimism

Sakar Healthcare’s recent price appreciation is underpinned by its impressive financial results over the past several quarters. The company has reported positive earnings for four consecutive quarters, signalling operational stability and growth momentum. In the latest six-month period, net sales surged to ₹110.30 crores, marking a substantial growth rate of 31.42%. This top-line expansion has translated into a healthy rise in profitability, with the profit after tax (PAT) reaching ₹9.21 crores, up 27.74% compared to the previous period. Such strong earnings growth has bolstered investor sentiment, contributing to the stock’s upward trajectory.

Market Outperformance and Technical Strength

Beyond fundam...

Sakar Healthcare Sees Revision in Market Evaluation Amid Positive Financial Trends

2025-11-30 10:24:23

Sakar Healthcare, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical indicators, providing investors with a refreshed view of its market position.

Sakar Healthcare Technical Momentum Shifts Signal Bullish Trends Amid Market Volatility

2025-11-28 08:07:24

Sakar Healthcare, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited notable shifts in its technical momentum, reflecting evolving market dynamics. Recent assessment changes highlight a transition towards bullish technical indicators, suggesting a potential strengthening in price trends despite mixed signals from volume-based metrics.

Sakar Healthcare Technical Momentum Shifts Amid Mixed Market Signals

2025-11-27 08:07:49

Sakar Healthcare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, underscoring the evolving market dynamics for this mid-cap stock.

Sakar Healthcare Technical Momentum Shifts Signal Renewed Market Interest

2025-11-26 08:09:08

Sakar Healthcare has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent assessment changes highlight a transition from a mildly bullish to a bullish technical trend, supported by key indicators such as MACD, moving averages, and Bollinger Bands, suggesting a renewed investor focus on the stock.

Sakar Healthcare Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:13:20

Sakar Healthcare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the importance of a detailed technical analysis for investors tracking this stock.

Sakar Healthcare Shows Resilience Amidst Mixed Financial Performance Indicators

2025-11-12 11:01:22

Sakar Healthcare has reported positive financial results for the quarter ending September 2025, with a notable increase in profit after tax and strong net sales. However, rising interest expenses and declining profitability metrics present challenges. The company has outperformed the Sensex, highlighting its market resilience.

How has been the historical performance of Sakar Healthcare?

2025-11-09 22:42:04

Answer: The historical performance of Sakar Healthcare shows a consistent growth trajectory in net sales and profitability over the past five years. Breakdown: Sakar Healthcare's net sales have increased from 94.74 Cr in Mar'21 to 177.58 Cr in Mar'25, demonstrating a strong upward trend. Total operating income has followed a similar pattern, rising from 94.74 Cr in Mar'21 to 177.58 Cr in Mar'25. The company's total expenditure has also grown, reaching 127.90 Cr in Mar'25, up from 72.14 Cr in Mar'21, primarily driven by rising raw material costs and employee expenses. Operating profit (PBDIT) has improved significantly, from 22.60 Cr in Mar'21 to 49.68 Cr in Mar'25, indicating enhanced operational efficiency. Profit before tax has increased from 13.23 Cr in Mar'21 to 21.53 Cr in Mar'25, while profit after tax has risen from 10.68 Cr in Mar'21 to 17.50 Cr in Mar'25. The company's earnings per share (EPS) hav...

Are Sakar Healthcare latest results good or bad?

2025-11-08 19:20:12

Sakar Healthcare's latest financial results for Q2 FY26 highlight a complex operational landscape characterized by significant revenue growth juxtaposed with margin compression and rising costs. The company reported a revenue of ₹52.74 crores, marking a 28.17% increase year-on-year and a 4.98% increase quarter-on-quarter, which reflects a strong sales performance. However, net profit was ₹4.67 crores, showing a substantial year-on-year increase of 93.78% but a decline of 18.92% compared to the previous quarter, indicating volatility in profitability. The operating margin, excluding other income, decreased to 24.10% from 26.00% year-on-year, signaling challenges in maintaining operational efficiency amidst rising employee costs and operational expenses that have outpaced revenue growth. The profit after tax margin improved to 8.85% year-on-year but fell from 11.46% in the previous quarter, suggesting potent...

View All News

Announcement

Sakar Healthcare Limited - Reply to Clarification- Financial results

09-Dec-2019 | Source : NSE

Sakar Healthcare Limitedealthcare Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sakar Healthcare Limited - Clarification - Financial Results

03-Dec-2019 | Source : NSE

Sakar Healthcare Limitede Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.